Roflair Tablet
Prescription Required
Product introduction
Roflair Tablet is used to prevent chronic obstructive pulmonary disease(COPD), group of lung disorders in which the flow of air to the lungs is blocked and chronic bronchitis. It works by opening the airways and makes breathing easier.
Roflair Tablet is used in the treatment of some breathing disorders due to swelling and redness in the lungs
Roflair Tablet is used in the treatment of some breathing disorders due to swelling and redness in the lungs
Uses of Roflair Tablet
Benefits of Roflair Tablet
In Chronic obstructive pulmonary disease (COPD)
Roflair Tablet helps the airways in your lungs stay open. It relaxes the muscles of these airways. This makes it easier for air to get in and out. It will relieve symptoms such as tightness in your chest, shortness of breath, wheezing and coughing and help you carry out your daily activities more easily. This medicine is safe and effective. It usually starts to work within a few minutes and the effects can last up to several hours. Do not stop using it unless you are advised to by your doctor.
Side effects of Roflair Tablet
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Common side effects of Roflair
- Headache
- Weight loss
- Insomnia (difficulty in sleeping)
- Nausea
- Diarrhea
- Decreased appetite
- Abdominal pain
How to use Roflair Tablet
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Roflair Tablet may be taken with or without food, but it is better to take it at a fixed time.
Safety advice
Alcohol
CONSULT YOUR DOCTOR
It is not known whether it is safe to consume alcohol with Roflair Tablet. Please consult your doctor.
Pregnancy
CONSULT YOUR DOCTOR
Roflair Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Breast feeding
CONSULT YOUR DOCTOR
Roflair Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Driving
SAFE
Roflair Tablet does not usually affect your ability to drive.
Kidney
SAFE IF PRESCRIBED
Roflair Tablet is safe to use in patients with kidney disease. No dose adjustment of Roflair Tablet is recommended.
Liver
CAUTION
Roflair Tablet should be used with caution in patients with liver disease. Dose adjustment of Roflair Tablet may be needed. Please consult your doctor.
Use of Roflair Tablet is not recommended in patients with moderate to severe liver disease.
Use of Roflair Tablet is not recommended in patients with moderate to severe liver disease.
All substitutes
For informational purposes only. Consult a doctor before taking any medicines.
Roflair Tablet
₹13.75/Tablet
Rofaday Tablet
Lupin Ltd
₹20.13/tablet
46% costlier
Filast 500 Tablet
Sun Pharmaceutical Industries Ltd
₹6.25/tablet
55% cheaper
Rofum Tablet
MSN Laboratories
₹13.68/tablet
1% cheaper
Rufus 500mcg Tablet
Glenmark Pharmaceuticals Ltd
₹12.5/tablet
9% cheaper
Spirolast Tablet
Koye Pharmaceuticals Pvt ltd
₹12.5/tablet
9% cheaper
Quick tips
- Roflair Tablet is used to treat chronic obstructive pulmonary disease (COPD).
- It should not be used for sudden attacks of breathlessness (acute bronchospasm).
- Consult your doctor if you experience unexplained and significant weight loss while on treatment.
- Avoid smoking and minimise your exposure to pollution, dust, and fumes. Along with that, a little exercise each day can help you stay strong.
Fact Box
Chemical Class
Benzamides Derivatives
Habit Forming
No
Therapeutic Class
RESPIRATORY
Action Class
Phosphodiesterase-IV inhibitors (COPD)
Patient concerns
User feedback
Patients taking Roflair Tablet
Once A Day
93%
Twice A Day
7%
What are you using Roflair Tablet for?
Chronic obstr*
50%
Others
25%
Asthma
25%
*Chronic obstructive pulmonary disorder (COPD)
FAQs
Is Roflair Tablet a methylxanthine?
No. Roflair Tablet is not a methylxanthine and works via a different mechanism of action
Is Roflair Tablet available in India?
Yes. Roflair Tablet is available in India in the form of 500 mcg tablet
Is Roflair Tablet a steroid/ narcotic?
No. Roflair Tablet belongs to a class of drugs called phosphodiesterase inhibitors. It does not have a chemical structure or effects similar to steroids. It does not induce sleep and is not a narcotic drug
What is Roflair Tablet used for?
Roflair Tablet is used as a maintenance treatment for severe chronic obstructive pulmonary disease (COPD; a group of lung disorders in which the flow of air to the lungs is blocked) in patients with frequent worsening of COPD symptoms (COPD exacerbations) and with long-term inflammation of airways (chronic bronchitis)
How does Roflair Tablet work?
Roflair Tablet is used to prevent worsening of symptoms in patients with severe chronic obstructive pulmonary disease (COPD; a group of lung disorders in which the flow of air to the lungs is blocked) and long-term inflammation of airways (chronic bronchitis)
How long does Roflair Tablet take to work?
Roflair Tablet may need to be taken for several weeks to achieve its effects and may vary upon individual response. Please follow advice of your doctor regarding dose and duration.
Disclaimer:
Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.References
- Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. p. 1232.
Marketer details
Name: Cipla Ltd
Address: Cipla House, Peninsula Business Park, Ganpatrao Kadam Marg, Lower Parel, Mumbai-400013
Country of origin: India
Lab tests offered by us
Related/Popular tests
MRP
₹137.5
Inclusive of all taxes
10.0 tablets in 1 strip
SOLD OUT
Notify me